로딩 중…
지수 로딩 중…
Ultragenyx Pharmaceutical Inc.
RARE· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$27.44+1.97%
2026-06-18
Price Chart
Ultragenyx Pharmaceutical Inc.-26.53%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $2.70B |
| Revenue | $669M |
| Net Income | $-609M |
| Total Assets | $1.30B |
| Net Assets | $151M |
| Value | |
| P/B | 17.86x |
| P/S | 4.04x |
| FCF Yield | -18.03% |
| Profitability | |
| ROA | -47.02% |
| Op. Margin | -83.92% |
| Revenue Growth | -2.36% |
| Financial Health | |
| Debt Ratio | 1008.02% |
| Total Debt | $1.20B |
| FCF | $-487M |
| Cash | $175M |
| Current Ratio | 2.02x |
| Performance | |
| 1Y Return | -26.53% |
| 1M Return | 22.23% |
| From 52W High | -35.24% |
| 1Y MDD | -55.36% |
| Trading | |
| Volume | 3,278,269 shares |
| Trading Value | $91M |
| Per Share | |
| EPS | $-5.76 |